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Figure S1. Expression of ACE2 across cell line models, related to Figure 1. A, Unsupervised 
hierarchical clustering of upper quartile-normalized RNA-seq reads. Normalized RNA-seq reads 
were aligned to the GRCh38 and Vervet-African green monkey genomes and quantified with 
Salmon (v1.3.0). As indicated, RNA-seq data were generated at UNC or Washington University 
or obtained from the Sequence Read Archive (SRA). B, Read counts for ACE2, GAPDH and 






































Figure S2. Visualization of SARS-Cov-2 replication and spread in H522 cells, related to 
Figure 1. A, Representative images of H522 cells infected with SARS-CoV-2 at the indicated time 
points and MOIs. H522 cells were fixed and stained for SARS-CoV-2 RNA (green) by RNAScope 
reagents and Nucleocapsid (N) protein (red) and imaged by confocal microscopy (n=2). B, 
Quantification of vRNA puncta in H522 cells infected with variable MOIs of SARS-CoV-2. Greater 
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ACE2 CRISPR KO Polyclonal Populations
44% 51% Cleavage Efficiency
ACE2 CRISPR KO Monoclonal Populations
   Ref:   5’-AACTTTTCCAGTACTGTAGATGGTGCTCATTGT
ACE2-/- MC-1:   5’-AACTTTTCC-----TGTAGATGGTGCTCATTGT
ACE2 sgRNA
ACE2-/- MC-2:   5’-AACTTTTCCAGTA-----GATGGTGCTCATTGT
ACE2+/+ MC:   5’-AACTTTTCCAGTACTGTAGATGGTGCTCATTGT
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D NRP1 CRISPR KO Monoclonal Populations
   Ref:   5’-TTTCTAGCCGGTCGTAGCGACAGAACATCCCCC
NRP1 sgRNA-1
NRP1+/+ MC:   5’-TTTCTAGCCGGTCGTAGCGACAGAACATCCCCC
cut site
NRP1-/- MC-1:  5’-TTTCTAGCCGGTCG----------ACATCCCCC
NRP1-/- MC-2:  5’-TTTCTAGC----------GACAGAACATCCCCC
   Ref:   5’-CTCCACTAGGTGTTGTGTAGTTCTGGGAACATT
NRP1 sgRNA-2
cut site
NRP1+/+ MC:   5’-CTCCACTAGGTGTTGTGTAGTTCTGGGAACATT
NRP1-/- MC-3:  5’-CTCCACTAGGTGTTGTGTAG------GAACATT
























Figure S3. ACE2 and NRP1 knockout via CRISPR in H522 and Calu-3 cell lines, related to 
Figure 3. A, Genomic Cleavage Detection Assay (Invitrogen) was performed following the 
manufacturer’s protocol on ACE2 WT or ACE2 KO CRISPR modified polyclonal cells. B, Sanger 
sequencing of genomic ACE2 at exon 3. Unique monoclonal populations of H522 ACE2 KO’s 
were aligned to the human genome (‘Ref’; hg38). The red dashed lines indicate small deletions 
within exon 3 of ACE2. C, Monoclonal populations of NRP1 CRISPR cells were infected with 
SARS-CoV-2 at an MOI: 1 i.u./cell and cell associated vRNA levels quantitated at 4 and 72 hpi 
(n= 3-6). D, Sanger sequencing of genomic NRP1 at exon 4. Unique monoclonal populations of 
H522 NRP1 KO’s were aligned to the human genome (‘Ref’; hg38). The red dashed lines indicate 
small deletions within exon 4 of NRP1.  E, NRP1 and AXL siRNA knockdown efficiencies in H522 



































































































































Figure S4. Comparative analysis of infection pathways in H522 and other permissive cells, 
related to Figure 4. H522, H522-ACE2 and Vero E6 cells were pre-treated with bafilomycin A 
(vATPase inhibitor), SGC-AAK1-1 (clathrin-mediated endocytosis inhibitor), E64D (endosomal 
cathepsins inhibitor), apilimod (PIKfyve inhibitor), or camostat mesylate (TMPRSS2 inhibitor) for 
1 h and then infected with SARS-CoV-2 in the presence of the inhibitors. Cell-associated SARS-
CoV-2 RNA was detected by qRT-PCR 24 hpi and normalized to DMSO treated cells (n≥3). * 
indicates p<0.05, ** indicates p<0.01, and *** indicates p<0.001 compared to DMSO treated 
controls where significance was determined using two-way ANOVA and the Dunnett correction 
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Figure S5. Protein interaction networks of differentially expressed proteins in H522 cells 
infected with SARS-CoV-2, related to Figure 6. Protein complexes of differentially expressed 
H522 and SARS-CoV-2 proteins. Complexes and functions were extracted from the CORUM 
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Figure S6. siRNA knockdown efficiency for viral sensing pathways in H522 cells, related 
to Figure 7. qRT-PCR for each gene targeted by siRNA in H522 cells. Knockdown efficiency was 
calculated compared to a non-targeting (NT) control. H522 cells were infected with SARS-CoV-2 
24 hpi and RNA was collected 24, 96, and 120 hpi. TLR8 mRNA was not detected across the 
three time points. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
